{
 "PrintNo":"S4842","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-02-15T12:59:18.06797Z",
 "Status":"IN_SENATE_COMM","Committee":"Insurance",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Insurance"}],
 "Actions":[
  {"Text":"REFERRED TO INSURANCE","Date":"2023-02-15","Chamber":"SENATE"},
  {"Text":"REFERRED TO INSURANCE","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[{"ID":1522,"Name":"Jake Ashby","Short":"ASHBY"}],
 "Title":"Provides that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization",
 "Summary":"Provides that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization.",
 "LawSection":"Insurance Law","LawCode":"Amd §§3216, 3221 & 4303, Ins L",
 "ActClause":"AN ACT to amend the insurance law, in relation to providing that coverage for outpatient diagnosis and treatment of substance use disorder shall not be subject to preauthorization",
 "PreviousVersions":["S8064-2017","S333-2019","S1915-2021"]
}